The civic record
Read. Follow. Verify.Pennsylvania Bill SB 1462 allows pharmacists to initiate, dispense, and administer HIV prevention medications
Last action · September 24, 2026: Referred to CONSUMER PROTECTION AND PROFESSIONAL LICENSURE, Sept. 24, 2026Sponsors: Amanda Cappelletti and 6 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Pennsylvania Senate Bill 1462 amends the Pharmacy Act to allow trained pharmacists to initiate, dispense, and administer preexposure (PrEP) and postexposure (PEP) HIV prevention medications without a traditional prescription, subject to statewide protocols. The legislation also authorizes pharmacists to order and perform related HIV tests under specific federal and state waivers and requires professional liability insurance of at least $1 million per occurrence.
Expands immediate public health access by permitting retail pharmacies to provide preventative HIV medications and testing directly to patients, bypassing the requirement for an initial physician's prescription while establishing specific clinical screening and referral duties for pharmacists.
- The Pharmacy Act of Pennsylvania regulates the practice of pharmacy and the distribution of drugs at retail across the Commonwealth. context
- Preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) are proven biomedical interventions used to prevent human immunodeficiency virus (HIV) infection. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Pharmacists
Pharmacists gain the legal authority to initiate, dispense, and administer HIV prevention medications and order or perform rapid tests, provided they complete required training and maintain $1 million in professional liability insurance.
Patients seeking HIV prevention medication
Patients can access PrEP and PEP medications and screening tests directly through participating pharmacies without needing a prior traditional prescription from a physician.
Medical practitioners
Primary care and HIV care physicians receive patient referrals following positive HIV screening results and are notified by pharmacists within 48 hours when PEP medication is initiated.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Can a pharmacist prescribe PrEP without a doctor's prescription under this bill?
How often can a pharmacist provide an initial supply of PrEP to the same patient?
What are the insurance requirements for pharmacists providing these HIV services?
What is required if a patient tests positive for HIV at the pharmacy?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
1 action- Sep 24, 2026SenateCommitteeReferred to CONSUMER PROTECTION AND PROFESSIONAL LICENSURE, Sept. 24, 2026
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expansion of Pharmacist Authority
The bill represents a targeted statutory exception to traditional collaborative agreement requirements, granting pharmacists direct authority to initiate specific preventive medications.
Connected Entities
Sources
www.palegis.us
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools